Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)
Food and Drug Administration
About This Grant
<p>The Food and Drug Administration's (FDA), Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND), is announcing this Funding Opportunity Announcement (FOA) for a Cooperative Agreement.</p><p><strong> </strong></p><p>The proposed work directly supports the U.S. FDA’s stated goal of protecting public health from unacceptable risks from nitrosamine impurities in human drugs. Although significant experimental and policy/regulatory initiatives have been undertaken in this area, there remains a need for further research into and development and refinement of translational and implementable practices that will protect the public against nitrosamine risks while ensuring continued safe access to critical therapeutic drugs. The aim is to improve the safety of human drugs with potential nitrosamine impurity liabilities.</p><p> </p><p>In addition to the work outlined above, the award recipient will assess how best to ensure that this research and practices development continues among industry members, non-profits, and/or academic institutions once the FDA funding for this cooperative agreement ends.</p>
Grant Summary
Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01) is a Food and Drug Administration grant providing $350K to $350K for tribal government, university, small business. Applications are accepted on a rolling basis. Check eligibility and apply with FindGrants.
Focus Areas
Eligibility
- Applicant organizations may submit more than one application, provided that each application is scientifically distinct.The FDA will not accept duplicate or highly overlapping applications under review at the same time. This means that the FDA will not accept:•A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.•A resubmission (A1) application that is submitted before issuance of the summary statementfrom the review of the previous new (A0) application.
How to Apply
$350K–$350K
Rolling / Open
- 1Confirm your organization is eligible for Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01) from Food and Drug Administration, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to Food and Drug Administration before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against Food and Drug Administration's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01): Frequently Asked Questions
Who is eligible for the Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)?
Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01) is offered by Food and Drug Administration and is generally open to tribal government, university, small business, municipality, nonprofit, healthcare org, school district. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01) provide?
Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01) provides between $350K and $350K per award from Food and Drug Administration. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01) deadline?
Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01) accepts applications on a rolling or ongoing basis, so there is no single fixed deadline. Confirm current timing with the funder, Food and Drug Administration, before you apply, and submit as early as possible because rolling programs can close once funds are committed.
How do you apply for the Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)?
To apply for Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01), confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from Food and Drug Administration.